2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
Accession Number
DB07312
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
Not Available
Categories
Not Available
UNII
Not Available
CAS number
Not Available
Weight
Average: 377.63
Monoisotopic: 375.924295911
Chemical Formula
C13H7Cl3N2O3S
InChI Key
JCXZHFCBNFFHRC-UHFFFAOYSA-N
InChI
InChI=1S/C13H7Cl3N2O3S/c14-7-2-4-11-10(5-7)17-13(21-11)18-22(19,20)12-6-8(15)1-3-9(12)16/h1-6H,(H,17,18)
IUPAC Name
2,5-dichloro-N-(5-chloro-1,3-benzoxazol-2-yl)benzene-1-sulfonamide
SMILES
ClC1=CC=C2OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=NC2=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
TargetActionsOrganism
UFructose-1,6-bisphosphatase 1Not AvailableHumans
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
6102820
PubChem Substance
99443783
ChemSpider
4810321
BindingDB
50181323
ChEMBL
CHEMBL207095
HET
A37
PDB Entries
2fhy

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0188 mg/mLALOGPS
logP4.18ALOGPS
logP4.3ChemAxon
logS-4.3ALOGPS
pKa (Strongest Acidic)6.58ChemAxon
pKa (Strongest Basic)-2.4ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area72.2 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity83.44 m3·mol-1ChemAxon
Polarizability33.15 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9975
Blood Brain Barrier+0.641
Caco-2 permeable-0.5132
P-glycoprotein substrateNon-substrate0.9073
P-glycoprotein inhibitor INon-inhibitor0.8353
P-glycoprotein inhibitor IINon-inhibitor0.8198
Renal organic cation transporterNon-inhibitor0.8735
CYP450 2C9 substrateNon-substrate0.5675
CYP450 2D6 substrateNon-substrate0.8091
CYP450 3A4 substrateNon-substrate0.6529
CYP450 1A2 substrateInhibitor0.6246
CYP450 2C9 inhibitorInhibitor0.7399
CYP450 2D6 inhibitorNon-inhibitor0.7732
CYP450 2C19 inhibitorInhibitor0.655
CYP450 3A4 inhibitorNon-inhibitor0.8149
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.8563
Ames testNon AMES toxic0.8152
CarcinogenicityNon-carcinogens0.7125
BiodegradationNot ready biodegradable1.0
Rat acute toxicity2.2137 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8073
hERG inhibition (predictor II)Non-inhibitor0.8818
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzenesulfonamides
Direct Parent
Benzenesulfonamides
Alternative Parents
Benzenesulfonyl compounds / Benzoxazoles / Dichlorobenzenes / Organosulfonamides / Aryl chlorides / Oxazoles / Aminosulfonyl compounds / Heteroaromatic compounds / Oxacyclic compounds / Azacyclic compounds
show 6 more
Substituents
Benzenesulfonamide / Benzoxazole / Benzenesulfonyl group / 1,4-dichlorobenzene / Chlorobenzene / Halobenzene / Aryl chloride / Aryl halide / Organosulfonic acid amide / Azole
show 20 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Targets

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Monosaccharide binding
Specific Function
Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating gl...
Gene Name
FBP1
Uniprot ID
P09467
Uniprot Name
Fructose-1,6-bisphosphatase 1
Molecular Weight
36842.145 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235]

Drug created on September 15, 2010 15:20 / Updated on September 02, 2019 18:34